Boxes of AstraZeneca COVID-19 vaccine manufactured by the Serum Institute of India and provided through the global COVAX initiative arrive at the airport in Mogadishu, Somalia Monday, March 15, 2021.
The first shipment of 300,000 doses of the AstraZeneca coronavirus vaccine will target the country's frontline workers, elderly and people with chronic health conditions, according to Somalia's Ministry of Health.
(AP Photo/Farah Abdi Warsameh)GENEVA – The U.N. health agency said its global rollout of coronavirus vaccines remains unaffected even as a growing number of countries, especially in Europe, suspended use of AstraZeneca’s vaccine on Monday amid concerns about blood clots in some people who received it.
The program began shipments in late February and has plans to ship more than 200 million doses by the end of May — nearly all of them versions of the Oxford-AstraZeneca vaccine.
AdDr. Soumya Swaminathan, WHO's chief scientist, noted that 300 million doses of coronavirus vaccines have been injected around the world, and there is no documented death linked to any one of them.